Cercar
01/07/2021
Improved office blood pressure control by automatic delayed-reading oscillometric device
Coll-Brito, V, Calero, F, Arias, P, Ayasreh, N, Ochoa, J, Ramos, A, Guirado, L, Fernandez-Llama, P. Improved office blood pressure control by automatic delayed-reading oscillometric device. Hipertension Y Riesgo Vascular. 2021; 38(3)DOI:10.1016/j.hipert.2021.03.002. PMID:33893057. IF:(Q/D).
01/07/2021
Bisphenol a Exposure and Kidney Diseases: Systematic Review, Meta-Analysis, and NHANES 03-16 Study
Moreno-Gomez-Toledano, R, Arenas, MI, Velez-Velez, E, Coll, E, Quiroga, B, Bover, J, Bosch, RJ. Bisphenol a Exposure and Kidney Diseases: Systematic Review, Meta-Analysis, and NHANES 03-16 Study. Biomolecules. 2021; 11(7)DOI:10.3390/biom11071046. PMID:34356670. IF:6.064(Q2/3D).
01/07/2021
Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry
Villanego, F, Mazuecos, A, Perez-Flores, IM, Moreso, F, Andres, A, Jimenez-Martin, C, Molina, M, Canal, C, Sanchez-Camara, LA, Zarraga, S, Ruiz-Fuentes, MD, Aladren, MJ, Melilli, E, Lopez, V, Sanchez-Alvarez, E, Crespo, M, Pascual, J. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry. AMERICAN JOURNAL OF TRANSPLANTATION. 2021; 21(7)DOI:10.1111/ajt.16579. PMID:33756067. IF:9.369(Q1/1D).
22/09/2022
Clinical and genetic characterization of a cohort of proteinuric patients with biallelic CUBN variants
Domingo-Gallego, A, Pybus, M, Madariaga, L, Pinero-Fernandez, JA, Gonzalez-Pastor, S, Lopez-Gonzalez, M, Simarro-Rueda, E, Quintanilla-Mata, ML, Matoses-Ruiperez, ML, Ejarque-Vila, L, Cornec-Le Gall, E, Guirado, L, Torra, R, Ariceta, G, Ars, E. Clinical and genetic characterization of a cohort of proteinuric patients with biallelic CUBN variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(10)DOI:10.1093/ndt/gfab285. PMID:34610128. IF:6.100(Q1/2D).
29/04/2022
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease
Naranjo, J, Furlano, M, Torres, F, Hernandez, J, Pybus, M, Ejarque, L, Cordoba, C, Guirado, L, Ars, E, Torra, R. Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 2022; 15(5)DOI:10.1093/ckj/sfab293. PMID:35498884. IF:4.600(Q1/2D).
25/04/2022
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
Muller, RU, Messchendorp, AL, Birn, H, Capasso, G, Cornec-Le Gall, E, Devuyst, O, van Eerde, A, Guirchoun, P, Harris, T, Hoorn, EJ, Knoers, NVAM, Korst, U, Mekahli, D, Le Meur, Y, Nijenhuis, T, Ong, ACM, Sayer, JA, Schaefer, F, Servais, A, Tesar, V, Torra, R, Walsh, SB, Gansevoort, RT. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(5)DOI:10.1093/ndt/gfab312. PMID:35134221. IF:6.100(Q1/2D).